Intermountain Health, the largest nonprofit healthcare provider in the Intermountain West region, struck a multi-year collaboration with a young generative AI startup this month. The health system is ...
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, ...
As previously reported, the single agent dose escalation of BI-1910 in the Phase 1 study was completed without any notable adverse eventsUpdated clinical data will be presented at the Society for ...
ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson’s disease –– ARV-102 demonstrated ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
(MENAFN- EIN Presswire) Leading healthcare data abstraction company evolves brand to better represent comprehensive clinical registry expertise across all medical specialties. While we built our ...
The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...
-- 30.2-month median progression-free survival with a median follow-up of 38.1 months in the Phase 1 study of anito-cel; median overall survival not reached -- -- Preliminary results from 58 patients ...
Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and inflammation and immunology (I&I), will present a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback